TET2 regulates extranodal NK/T cell lymphoma progression through regulation of DNA methylation
Authors:
- 9 July 2024
- journal article
- research article
- Published by Wiley in Hematological Oncology
- Vol. 42 (4) , e3295
Abstract
The biological role of Ten‐11 translocation 2 (TET2) and the conversion of 5‐methylcytosine (5mC) to 5‐hydroxymethylcytosine (5hmC) in the development of extra‐nodal natural killer/T‐cell lymphoma (ENKTL) remains unclear. The level of 5mC and 5hmC was detected in 112 cases of ENKTL tissue specimens by immunohistochemical (IHC) staining. Subsequently, TET2 knockdown and the overexpression cell models were constructed in ENKTL cell lines. Biochemical analyses were used to assess proliferation, apoptosis, cell cycle and monoclonal formation in cells treated or untreated with L‐Ascorbic acid sodium salt (LAASS). Dot‐Blots were used to detect levels of genome 5mC and 5hmC. Additionally, the ILLUMINA 850k methylation chip was used to analyze the changes of TET2 regulatory genes. RNA‐Seq was used to profile differentially expressed genes regulated by TET2. The global level of 5hmC was significantly decreased, while 5mC was highly expressed in ENKTL tissue. TET2 protein expression was negatively correlated with the ratio of 5mC/5hmC (p < 0.0001). The 5mC/5hmC status were related to the site of disease, clinical stage, PINK score and Ki‐67 index, as well as the 5‐year OS. TET2 knockdown prolonged the DNA synthesis period, increased the cloning ability of tumor cells, increased the level of 5mC and decreased the level of 5hmC in ENKTL cells. While overexpression of TET2 presented the opposite effect. Furthermore, treatment of ENKTL cells with LAASS significantly induced ENKTL cell apoptosis. These results suggest that TET2 plays an important role in ENKTL development via regulation of 5mC and 5hmC and may serve as a novel therapeutic target for ENKTL.Keywords
Funding Information
- National Natural Science Foundation of China (81900197)
This publication has 19 references indexed in Scilit:
- Extranodal NK/T cell lymphoma, nasal type: An updated overviewCritical Reviews in Oncology/Hematology, 2021
- Improved functional and nutritional properties of tomato fruit during cold storageSaudi Journal of Biological Sciences, 2020
- Genomic and Transcriptomic Characterization of Natural Killer T Cell LymphomaCancer Cell, 2020
- SIRT1 Activation Disrupts Maintenance of Myelodysplastic Syndrome Stem and Progenitor Cells by Restoring TET2 FunctionCell Stem Cell, 2018
- Cooperative Epigenetic Remodeling by TET2 Loss and NRAS Mutation Drives Myeloid Transformation and MEK Inhibitor SensitivityCancer Cell, 2018
- A Phase II Study of Methotrexate, Etoposide, Dexamethasone and Pegaspargase Sandwiched with Radiotherapy in the Treatment of Newly Diagnosed, Stage IE to IIE Extranodal Natural-Killer/T-Cell Lymphoma, Nasal-TypeEBioMedicine, 2017
- Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia ProgressionCell, 2017
- The DNA Methylcytosine Dioxygenase Tet2 Sustains Immunosuppressive Function of Tumor-Infiltrating Myeloid Cells to Promote Melanoma ProgressionImmunity, 2017
- DNA methylation and hydroxymethylation in hematologic differentiation and transformationCurrent Opinion in Cell Biology, 2015
- Tet2 Loss Leads to Increased Hematopoietic Stem Cell Self-Renewal and Myeloid TransformationCancer Cell, 2011